✦ LIBER ✦

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

✍ Scribed by Hirsch, F R; Varella-Garcia, M; Cappuzzo, F

Book ID: 109971001
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 28
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2009.199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR / HER2 / HER3 expression in tumour

EGFR / HER2 / HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-small cell lung cancer

✍ Jianming Xu; Emei Gao; Yu Han; Yang Zhang; Suxia Li; Xiaoqing Liu; Zhiqiang Li; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 282 KB

Overexpression of cyclooxygenase-2 in no

Overexpression of cyclooxygenase-2 in non-small cell lung cancer

✍ D.K. Petkova; C. Clelland; J. Ronan; L. Pang; J.M. Coulson; S. Lewis; A.J. Knox 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 434 KB

CN2 ECONOMIC EVALUATION OF EGFR-GUIDEDTR

CN2 ECONOMIC EVALUATION OF EGFR-GUIDEDTREATMENT IN ADVANCED REFRACTORY NON SMALL-CELL LUNG CANCER

✍ JJ Carlson; L Garrison; S Ramsey; DL Veenstra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

P17 EGFR, K-RAS and HER2 mutations as pr

P17 EGFR, K-RAS and HER2 mutations as predictive factors for gefitinib sensitivity in non-small cell lung cancer (NSCLC)

✍ A. Voutsina; A. Kalikaki; Y. Ampatziadis-Michailidis; J. Souglakos; A. Koytsopoy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

HMGA2 overexpression in non-small cell l

HMGA2 overexpression in non-small cell lung cancer

✍ Britta Meyer; Siegfried Loeschke; Anke Schultze; Thomas Weigel; Martin Sandkamp; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

## Abstract Lung cancer is still the leading cause of death from cancer worldwide primarily because of the fact that most lung cancers are diagnosed at advanced stages. Overexpression of the high mobility group protein HMGA2 has been observed in a variety of malignant tumors and often correlates wi

Advances in anti-VEGF and anti-EGFR ther

Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer

✍ Reck, Martin; Crinò, Lucio 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 190 KB